Free Trial

Candel Therapeutics (CADL) SEC Filings & 10K Form

Candel Therapeutics logo
$12.21 +1.74 (+16.62%)
Closing price 02/20/2025 04:00 PM Eastern
Extended Trading
$12.21 0.00 (0.00%)
As of 02/20/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Candel Therapeutics SEC Filings

DateFilerForm TypeView
02/14/2025
4:32 PM
Candel Therapeutics (Subject)
Northpond Ventures, LP (Filed by)
Form SCHEDULE 13G/A
02/14/2025
3:30 PM
Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM
Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM
Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
5:25 AM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:09 PM
Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:18 AM
Candel Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:03 AM
Candel Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G
01/15/2025
7:30 AM
Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM
Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM
Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM
Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM
Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
7:05 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:30 PM
Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM
Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM
Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:27 AM
Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:27 AM
Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:28 AM
Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:28 AM
Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:29 AM
Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/30/2024
6:37 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
12:59 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:11 PM
Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
11:30 AM
Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G
12/13/2024
5:12 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:30 PM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
3:36 PM
Candel Therapeutics (Filer)
Form 424B5
12/12/2024
3:55 PM
Candel Therapeutics (Filer)
Form 424B5
12/11/2024
6:45 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
5:44 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:46 PM
Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:47 PM
Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:48 PM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:48 PM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
8:12 AM
Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)

Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?

That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y
11/29/2024
8:13 AM
Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
8:15 AM
Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
8:17 AM
Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
5:24 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
2:07 PM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
7:30 AM
Candel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
7:15 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:58 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
5:08 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
5:41 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
7:30 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:59 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
5:19 PM
Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
4:16 PM
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
4:53 PM
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
7:15 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:30 AM
Candel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
7:26 AM
Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
7:28 AM
Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
7:29 AM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
7:31 AM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
7:24 AM
Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
6:28 AM
Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:29 AM
Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:31 AM
Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:32 AM
Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
6:27 AM
Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
7:32 AM
Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:34 AM
Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:35 AM
Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:36 AM
Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:30 AM
Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
6:33 AM
Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
6:35 AM
Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
6:36 AM
Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
6:37 AM
Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
6:38 AM
Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2024
7:39 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
7:40 AM
Candel Therapeutics (Issuer)
Nguyen Diem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:41 AM
Candel Therapeutics (Issuer)
PAPA JOSEPH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:34 AM
Benz Edward J. JR (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:35 AM
Candel Therapeutics (Issuer)
Gaeta Renee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:36 AM
Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:37 AM
Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:39 AM
Candel Therapeutics (Issuer)
Martell Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:39 AM
Candel Therapeutics (Issuer)
Nabel Gary J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:20 PM
Candel Therapeutics (Filer)
Form ARS
05/30/2024
3:30 PM
Candel Therapeutics (Filer)
Form DEF 14A
05/24/2024
6:30 AM
Candel Therapeutics (Filer)
Form 424B5
05/23/2024
4:05 PM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)

Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?

That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y
05/14/2024
7:30 AM
Candel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
7:15 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
7:30 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
6:33 AM
Candel Therapeutics (Filer)
Form 10-K/A
04/11/2024
8:00 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
7:30 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
7:30 AM
Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
7:00 AM
Candel Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
7:16 AM
Candel Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CADL) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners